HighTower Advisors
GOSS icon

HighTower Advisors’s Gossamer Bio GOSS Stock Holding History

HighTower Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Buy
144,358
+78,728
+120% +$22K ﹤0.01% 3765
2026
Q1 		$21.6K Sell
65,630
-864
-1% -$1.36K ﹤0.01% 3754
2025
Q4 		$206K Buy
66,494
+46,993
+241% +$134K ﹤0.01% 3353
2025
Q3 		$51.3K Buy
+19,501
New +$43K ﹤0.01% 3606

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

HighTower Advisors's GOSS Position: Q2 2026 in Review

HighTower Advisors increased its Gossamer Bio (GOSS) stake by 120% in Q2 2026, buying an estimated $22K and bringing the position to 144,358 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3765.

HighTower Advisors first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $206K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • HighTower Advisors held 144,358 shares of Gossamer Bio worth $23.8K as of Q2 2026.
  • HighTower Advisors bought 78,728 Gossamer Bio shares in Q2 2026, an estimated $22K.
  • Gossamer Bio made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3765 holding.
  • HighTower Advisors first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • HighTower Advisors's Gossamer Bio position peaked at $206K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.